非典型股骨骨折患者骨密度T值不一致性研究
该回顾性研究纳入48例女性非典型股骨骨折(AFF)患者,评估股骨与脊柱T值分类不一致的患病率,并与114例股骨转子间骨折(ITFF)女性患者比较。AFF组不一致患病率71%,显著高于ITFF组的23%(p < 0.001);AFF组中不一致组双膦酸盐起始年龄(65.7岁)低于一致组(70.7岁)(p = 0.04)。
要点
- AFF患者股骨与脊柱T值不一致患病率为71%,显著高于ITFF患者的23%(p < 0.001)。
- AFF组中不一致组双膦酸盐起始平均年龄65.7岁,低于一致组的70.7岁(p = 0.04)。
- AFF患者T值一致、次要不一致、主要不一致分别占29%、67%、4%。
核心结论
- AFF患者髋部与腰椎间T值不一致的患病率相对较高,且本研究中T值不一致患者的推测双膦酸盐起始年龄更年轻。
研究设计与样本
- 回顾性评估63例连续治疗的AFF患者病历,最终48例女性患者符合纳入标准;另与114例女性ITFF患者比较不一致患病率。
主要发现
- AFF患者T值一致、次要不一致、主要不一致分别占29%(14例)、67%(32例)、4%(2例)。
- AFF组不一致患病率71%,显著高于ITFF组的23%(p < 0.001)。
- AFF组中不一致组双膦酸盐起始平均年龄65.7岁,低于一致组的70.7岁(p = 0.04)。
- AFF患者骨折时平均年龄73.0岁,双膦酸盐平均使用时长68.5个月,推测双膦酸盐起始平均年龄67.2岁。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although atypical femoral fracture (AFF) occurs more frequently in patients taking bisphosphonates and longer treatment is associated with higher risk, the causal relationship between AFF and bisphosphonates has not been established. Most patients with AFF have osteoporosis that is being treated with bisphosphonates, but we are not aware of any reports regarding the areal bone mineral density (aBMD) and discordance between the T-scores of the femur and spine in such patients. We investigated the prevalence of aBMD discordance and the characteristics of patients with AFF. METHODS: Medical records for 63 consecutive patients treated for AFF were retrospectively evaluated, and 48 patients, all female, were eligible for the study. The average age at the time of fracture was 73.0 years, the average duration of bisphosphonate use was 68.5 months, and the average presumed age at bisphosphonate initiation was 67.2 years. We evaluated the prevalence of discordance, defined as a difference between the T-score categories of the femur and spine in the same individual as well as demographic differences between the discordance and concordance groups. We also compared the prevalence of discordance in patients with AFF with that in 114 female patients with intertrochanteric femoral fracture (ITFF). RESULTS: T-score concordance, minor discordance, and major discordance were seen in 14 (29%), 32 (67%), and 2 (4%) of the patients with AFF, respectively. The prevalence of discordance was significantly higher in those with AFF (71%) than in those with ITFF (23%) (p < 0.001). The average age at bisphosphonate initiation in the AFF group was lower in the discordance group (65.7 years) than in the concordance group (70.7 years) (p = 0.04). CONCLUSIONS: The prevalence of T-score discordance between the hip and lumbar spine was relatively high in patients with AFF, and the presumed age at the initiation of bisphosphonate therapy was younger in patients with discordant T-scores in this study. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Lee KJ, Min BW, Song KS, et al. T-Score Discordance of Bone Mineral Density in Patients with Atypical Femoral Fracture. J Bone Joint Surg Am. 2017. PMID: 28976433. doi:10.2106/JBJS.16.01440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。